SUSTAIN Efficacy and safety of semaglutide versus canagliflozin (Invokana®) as add-on to metformin in subjects with type 2 diabetes

March 17, 2017
https://clinicaltrials.gov/ct2/show/NCT03136484
Diabetes, Endocrinology
Principal Investigator: Davida F Kruger, NP
Diabetes, Type 2, Type 2 Diabetes
In Progress